Organicell Regenerative Medicine, Inc.


0.01 (USD) • At close November 27, 2023
Bedrijfsnaam Organicell Regenerative Medicine, Inc.
Symbool OCEL
Munteenheid USD
Prijs 0.007
Beurswaarde 10,051,230
Dividendpercentage 0%
52-weken bereik 0.005 - 0.052
Industrie Biotechnology
Sector Healthcare
CEO Dr. Harry L. Leider FACPE, M.B.A., M.D., MBA

An error occurred while fetching data.

Over Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any

Vergelijkbare Aandelen

Cell Source, Inc. logo

Cell Source, Inc.


0.498 USD

Provectus Biopharmaceuticals, Inc. logo

Provectus Biopharmaceuticals, Inc.


0.149 USD

Vext Science, Inc. logo

Vext Science, Inc.


0.215 USD

Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc.


0.98 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)